Aytu BioPharma Inc. (AYTU)
NASDAQ · Healthcare
Aytu BioPharma Inc. Operating Income 2014–2025
Aytu BioPharma Inc. annual/quarterly operating income history and growth rate from 2014 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Aytu BioPharma Inc. operating income for the quarter ending March 31, 2026 was -4.1 M, a 267.86% decrease year-over-year.
- Aytu BioPharma Inc. operating income for the twelve months ending March 31, 2026 was -5.1 M, a 375.56% increase year-over-year.
- Aytu BioPharma Inc. annual operating income for 2025 was -7.8 M, a 391.95% increase from 2024.
- Aytu BioPharma Inc. annual operating income for 2024 was -1.6 M, a 90.68% decrease from 2023.
- Aytu BioPharma Inc. annual operating income for 2023 was -17.1 M, a 84.47% decrease from 2022.
- Aytu BioPharma Inc. annual operating income for 2022 was -109.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aytu BioPharma Inc. Operating Income — FAQ
Aytu BioPharma Inc. (AYTU) operating income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is Aytu BioPharma Inc.'s operating income?
Aytu BioPharma Inc. (AYTU) reported operating income of -$8M for fiscal 2025.
Where can I see AYTU's operating income history?
The chart and table above show Aytu BioPharma Inc.'s operating income by year and by quarter, including the growth rate.